Abstract
Uridine, a pyrimidine nucleoside essential for the synthesis of RNA and biomembranes, was radiolabeled with 99mTc to obtain a potential tumor imaging agent. The maximal radiochemical yield of about 96.5%, as determined by paper chromatography and instant thin-layer chromatography, was reached under the following optimum conditions: 1 mg of uridine, 20 μg of SnCl2·2H2O as reducing agent, 20 mg of mannitol as a stabilizer, and pH 8. 99mTc-uridine is stable in vitro at room temperature for up to 6 h post labeling. The biodistrbution study in tumor-bearing mice shows high target-to-nontarget ratio. These results match with the high docking score of the complex on uridine phosphorylase enzyme. 99mTc-uridine shows promise as a tumor imaging agent.
Similar content being viewed by others
References
Cansev, M., Brain Res. Rev., 2006, vol. 52, no. 2, pp. 389–397.
Wurtman, R.J., Ulus, I.H., Cansev, M., et al., Brain Res., 2006, vol. 1088, no. 1, pp. 83–92.
De Jong, R.M., Willemsen, A.T.M., Slart, R.H.J.A., et al., Eur. J. Nucl. Med. Mol. Imag., 2005, vol. 32, p. 443.
Kanzaki, A., Takebayashi, Y., Bando, H., et al., Int. J. Cancer, 2002, vol. 97, pp. 631–635.
Deliang, C., Amy, Z., James, M.C., et al., Mol. Cancer Ther., 2011, vol. 10, no. 12, pp. 2330–2339.
Watanabe, S. and Uchida, T., Biochem. Biophys. Res. Commun., 1995, vol. 216, pp. 265–272.
Yamamoto, T., Koyama, H., Kurajoh, M., et al., Clin. Chim. Acta, 2011, vol. 412, nos. 19–20, pp. 1712–1724.
Pizzorno, G., Cao, D., Leffert, J.J., et al., Biochim. Biophys. Acta, 2002, vol. 1587, pp. 133–144.
Strauss, A.D., Strauss, L.G., Schlag, P., et al., J. Nucl. Med., 1998, vol. 39, pp. 1197–1202.
Presant, C.A., Wolf, W., Waluch, V., et al., Lancet, 1994, vol. 343, pp. 1184–1187.
Kumar, S., Kumar, M.A., Chhikara, B.S., et al., Hellen. J. Nucl. Med., 2008, vol. 11, no. 2, pp. 91–95.
Desbouis, D., Struthers, H., Spiwok, V., et al., J. Med. Chem., 2008, vol. 51, no. 21, pp. 6689–6698.
Vincent, P.C. and Nicholls, A., Cancer Res., 1967, vol. 27, no. 6, part 1, pp. 1058–1065.
Brooks, B.R., Brooks, C.L., MacKerell, A.D., et al., J. Comput. Chem., 2009, vol. 30, no. 10, pp. 1545–1614.
Savonova, T.S., Mikhailov, S.N., Monuvera, V.A., et al., Acta Crystallogr., Sect. D, 2014, vol. 70, pp. 3310–3319.
Banerjee, S.R., Maresca, K.P., Stephenson, K.A., et al., Bioconjugate Chem., 2005, vol. 16, pp. 885–902.
Khairul, I., Shaikh, M.M.A., and Jahan, A.K., Cancer Biol. Med., 2012, vol. 9, no. 4, pp. 242–247.
Nabila, Z., Enaiat, K., and Fatma, Z.S., World J. Pharm. Res., 2015, vol. 4, no. 4, pp. 272–286.
Arulsudar, N., Subramanian, N., Mishra, P., et al., AAPS Pharm. Sci., 2004, vol. 6, no. 1, pp. 45–56.
Rhodes, B.A., Semin. Nucl. Med., 1974, vol. 4, p. 281.
John, H.B. and John, M.B., Wilson and Gisvold’s Textbook of Organic Medicinal and Pharmaceutical Chemistry, USA: Lippincott Williams and Wilkins, 2004, 11th ed.
Lambrecht, Y., Durkan, K., and Unak, P., J. Radioanal. Nucl. Chem., 2008, vol. 275, no. 1, pp. 161–164.
Azuma, M. and Takahashi, J., US Patent 5 015 462 A, 1991.
Elmaleh, D.R. and Babich, J.W., US Patent 6 187 286 B1, 2001.
Zolle, I., Technetium-99m Radiopharmaceuticals: Preparation and Quality Control in Nuclear Medicine, Berlin: Springer, 2007.
Lomozik, L. and Jastrzab, R., J. Solution Chem., 2007, vol. 36, pp. 357–374.
Vieira, M.R., Modern Trends in Radiopharmaceuticals for Diagnosis and Therapy, Vienna: IAEA, 1998.
Johan, V.V., Jan, B.S., and Sandra, L., EXCLI J., 2014, vol. 13, pp. 300–322.
Von Brostel, R. and Bamat, B.M., US Patent 5 583 117, 1996.
Liu, T., Gan, Q., and Zhang, J., Chem. Biol. Drug Des., 2017, vol. 89, pp. 277–284.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Radiokhimiya, 2018, Vol. 60, No. 1, pp. 49–54.
The text was submitted by the authors in English.
Rights and permissions
About this article
Cite this article
Talaat, H.M., Ibrahim, I.T., Bayomy, N.A. et al. Synthesis of 99mTc-Radiolabeled Uridine as a Potential Tumor Imaging Agent. Radiochemistry 60, 51–57 (2018). https://doi.org/10.1134/S1066362218010095
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1066362218010095